Concepedia

Publication | Open Access

Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial

DOIFull Paper Access

194

Citations

18

References

2018

Year

Christoph Wanner, Hiddo J.L. Heerspink, Bernard Zinman, Silvio E. Inzucchi, Audrey Koitka‐Weber, Michaela Mattheus, Stefan Hantel, Hans‐Juergen Woerle, Uli C. Broedl, Maximilian von Eynatten,
Journal of the American Society of Nephrology

Abstract

The hemodynamic effects of empagliflozin, associated with reduction in intraglomerular pressure, may contribute to long-term preservation of kidney function.

References

YearCitations

Page 1